Driving Fast, Accurate Diagnosis for All Skin Cancers
About AI Medical Technology
We are dedicated to developing AI powered diagnostic solutions that enable frontline healthcare practitioners to make easier, faster and more reliable diagnoses for their patients.
Our first product, Dermalyser, is undergoing clinical validation as a decision support tool for the diagnosis of all skin cancers.
Our Background
AI Medical Technology is a company operating in the interdisciplinary fields of data science, software development, and medicine. Founded by a diverse team of driven, passionate tech entrepreneurs, software developers and clinicians, we are dedicated to developing AI powered diagnostic solutions that enable frontline healthcare practitioners to make easier, faster, more cost effective and more reliable diagnoses for their patients.
Having raised initial funding in 2021 we are now focussed on bringing our first solution, Dermalyser, through clinical trials and into market.
Meet Our Team
We are a cross disciplinary team of computer scientists, clinicians and entrepreneurs united by our passion to develop solutions that harness the power of AI which enable healthcare providers to provide easier, faster and more cost effective diagnosis.
Christoffer Ekström is one of the founders of AI Medical Technology and is the company’s CEO and one of the board members. He is a serial entrepreneur and holds a Master’s degree in immersive technologies (M.Sc.) from Stockholm University and finalising a
bachelor’s degree in business administration (BBA) at Uppsala University. Christoffer is an experienced climber and adventurer.
.
Jonatan Helenason is one of the founders of AI Medical Technology, and besides working as a lead developer, he is the company’s Supply Manager. He holds a Master’s degree in immersive technologies (M.Sc.) from Stockholm University. While Jonatan enjoys travelling, he is, in the most positive sense, a nerd at heart and loves everything about programming, popular science and new technology.
Jens Dolve is one of the founders of AI Medical Technology and is the company’s CFO. Previous experience includes Ernst & Young, Capgemini within Assurance, Transaction Advisory and Finance Transformation. Jens holds a M.Sc. in Economics and Business Administration from Lund’s University and studies in Financial Management at Sydney University.
Panos Papachristou is a co-founder of AI Medical Technology. He is a specialist physician in Family Medicine with a broad background from the fields of Biomedicine and Medicine.
He holds a PhD from Karolinska Institutet where he is affiliated to continued research. Panos is a passionate serial house renovator.
Niya Thomas is our Quality and Regulatory Affairs manager. She holds her global masters degree in Bio-entrepreneurship from Karolinska Institutet and a dual BS-MS degree in biological sciences from Indian Institute of Science Education and Research Thiruvananthapuram. A young culinary aficionado at heart, Niya enjoys her weekends going on culinary jaunts with her friends, exploring Stockholm’s diverse food scene.
Meet Our Board
Pär Nordström holds a Master’s degree in engineering physics from KTH. With more than three decades in the global medical device industry, then serving as an Investment manager at Almi Invest, he has gained extensive experience in Medical devices, board work and startups. He currently serves on the board of three medical technology startups. Apart from his engagement in Medtech startups, he enjoys spending time in his house and on the golf courses in Southern Sweden.
Agneta Franksson holds an MBA from Uppsala University and a Master’s degree from KTH, Stockholm. She has more than 25 years of experience in R&D, including clinical trials, product development, sales, marketing and CEO roles. Recently she has served as Sales Director at Tieto Healthcare & Welfare. Agneta has worked on about twenty boards since 2012. Her board experience spans both owner-managed and public companies, and she has received the national award “Supergasell 2016”, Dagens Industri.
Björn Ursing is a member of the board and also heads a life science initiative at The Netherlands Embassy in Stockholm, connecting the life science sectors in Sweden and The Netherlands. Björn has a broad life science background with experience as an Associate professor at Karolinska Institutet, a senior scientist in pharma, a COO in Danish biotech and consultant. Björn has mainly been engaged in MDR’s implications for startups in supporting roles. When not in the office, Björn enjoys playing golf and skiing.
Victoria Hellstrand has many years of experience in the Life Science and Medtech industries working with sales, medical marketing, pharmaceutical development, and clinical trial management. Victoria manages cross-functional teams, specialising in the launch of rare diseases, orphan drugs, and lifecycle management of mature products. She is committed to the patient perspective and collaborations together with patient organisations. Victoria loves spending time with family and friends, and being outdoors with her dogs.
Magnus Falk is a general practitioner and associate professor in general practice at Linköping University. He has broad and long-time experience as a clinical researcher in the field of skin cancer diagnosis and prevention, with specific emphasis on primary care, including methods to improve early skin cancer detection. Besides his scientific publications, he also enjoys writing novels in his leisure time.